Provided by Tiger Fintech (Singapore) Pte. Ltd.

Centessa Pharmaceuticals plc

12.30
-0.0900-0.73%
Post-market: 12.540.2400+1.95%17:19 EDT
Volume:509.88K
Turnover:6.30M
Market Cap:1.64B
PE:-5.97
High:12.85
Open:12.33
Low:12.09
Close:12.39
Loading ...
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Major Issues Report

8-K - Current report
Nov 01, 2021

Major Issues Report

8-K - Current report
Oct 04, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 11, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 26, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 26, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 24, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 20, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 12, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 11, 2021

Correspondence

CORRESP [Cover] - Correspondence